Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for J9298. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
31
Median % of Medicare
--
Rate range
$169.47 - $206.46
J9298 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Alabama | $197.83 | -- | -- | 2026 |
| Arkansas | $180.64 | -- | -- | 2026 |
| Arizona | $184.17 | -- | -- | 2026 |
| California | $201.76 | -- | -- | 2026 |
| Connecticut | $201.65 | -- | -- | 2026 |
| District of Columbia | $201.65 | -- | Required | 2026 |
| Iowa | $180.37 | -- | -- | 2024 |
| Idaho | $174.23 | -- | Not required | 2026 |
| Illinois | $196.31 | -- | -- | 2026 |
| Indiana | $206.46 | -- | -- | 2026 |
| Kansas | $205.51 | -- | -- | 2026 |
| Kentucky | $201.65 | -- | -- | 2026 |
| Louisiana | $193.86 | -- | -- | 2026 |
| Maine | $205.51 | -- | -- | 2026 |
| Michigan | $205.51 | -- | -- | 2026 |
| Minnesota | $205.51 | -- | Required | 2026 |
| Mississippi | $201.76 | -- | -- | 2026 |
| Montana | $201.65 | -- | -- | 2026 |
| Nebraska | $205.51 | -- | -- | 2026 |
| New Hampshire | $196.63 | -- | Not required | 2026 |
| New Jersey | $169.47 | -- | Not required | 2026 |
| New Mexico | $193.86 | -- | -- | 2025 |
| Oklahoma | $205.51 | -- | -- | 2026 |
| South Carolina | $197.10 | -- | -- | 2026 |
| Texas | $197.65* | -- | -- | 2026 |
| Utah | $205.51* | -- | Not required | 2026 |
| Virginia | $205.51* | -- | -- | 2026 |
| Vermont | $187.94 | -- | Required | 2026 |
| Washington | $205.51 | -- | -- | 2026 |
| Wisconsin | $205.51 | -- | -- | 2026 |
| Wyoming | $194.08* | -- | -- | 2025 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related drugs codes
- J0013 - Esketamine, nasal spray, 1 mg
- J0120 - Injection, tetracycline, up to 250 mg
- J0121 - Injection, omadacycline, 1 mg
- J0122 - Injection, eravacycline, 1 mg
- J0129 - Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0130 - Injection abciximab, 10 mg
- J0131 - Injection, acetaminophen, not otherwise specified,10 mg
- J0132 - Injection, acetylcysteine, 100 mg
All 198 codes from J9000 to J9601 or every drugs code by number.
Frequently asked questions
How much does Medicaid pay for J9298?
31 state Medicaid programs publish a fee-for-service rate for J9298 (injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg), ranging from $169.47 in New Jersey to $206.46 in Indiana. The full table on this page lists every publishing state's current rate.
Which state pays the most for J9298?
Indiana publishes the highest Medicaid rate for J9298 at $206.46. New Jersey publishes the lowest at $169.47.
Does J9298 require prior authorization under Medicaid?
3 of the 31 publishing states flag J9298 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".